Whereas Payne et al, looked simply at the presence or absence of EGFR expression, we developed a quantitative scoring criteria with four expression levels 0,1, 2 and 3 based on lung cancer cell lines that span the spectrum of EGFR expression observed in lung cancer from an IHC score of 0 to 3. The gene discussed is EGFR; the disease is lung carcinoma.